Abstract
Purpose
To assess the clinical efficacy of ibopamine eye drops in severe hypotony secondary to chronic progressive uveitis.
Methods
Case report. A 47-year-old man with a 37-year history of diffuse uveitis and severe refractory hypotony was treated with topical 2% ibopamine (Trazyl®) six times a day. Intraocular pressure, visual acuity, visual field and side effects were recorded during 15 months of follow-up.
Results
IOP, visual acuity and visual field increased after four days of therapy and lasted for two months when the drug was suspended because of the onset of filamentous keratopathy. A new course of treatment with 2% ibopamine eye drops in a different solvent (BSS®) resulted in a stable increase in IOP, VA and visual field, with no side effects in a follow-up of 13 months.
Conclusions
Ibopamine 2% eye drops in BSS® solvent seem effective in the treatment of uveitis-related hypotony.
Keywords
Get full access to this article
View all access options for this article.